// App-Quantinova.ai

EP592 : MANAGEMENT OF MENINGOCOCCAL DISEASE RISK IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON COMPLEMENT INHIBITORS: 18 YEARS’ EXPERIENCE FROM THE UK NATIONAL PNH SERVICE IN LEEDS

Researchers

Presenter

  • Louise Arnold

Principal Investigators

  • Ray Burrow

  • Kathryn Riley

  • Talha Munir

  • Richard Kelly

  • Rachael Jones

  • jeanifer Gachev

  • Briony Forrest

  • Alexander Pike

  • Petra Muus

  • Peter Hillmen

  • Morag Griffin

Medical Centers

  • Haematology,Public health England,Manchester,United Kingdom

  • Haematology,LTHT,Leeds,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

  • Sepsis

Biomarkers

  • N/A

Drug/Treatment

  • Penicillin

  • Benzylpenicillin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved